1
|
Thieme D, Anielski P, Rzeppa S, Wolf CA, Wolber G, Keiler AM. Detection of 18-methyl steroids - case report on a forensic urine sample and corresponding dietary supplements. Drug Test Anal 2022; 14:1864-1870. [PMID: 36258640 DOI: 10.1002/dta.3389] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/30/2022] [Revised: 10/12/2022] [Accepted: 10/12/2022] [Indexed: 11/05/2022]
Abstract
The detection of putative 18-methyl-19-nortestosterone metabolite in a forensic bodybuilder's urine sample collected as part of a criminal proceeding has triggered a follow up investigation. Four different dietary supplements in the possession of the suspect were examined with regard to possible precursor steroids. This led to the detection of the declared ingredient methoxydienone, which was confirmed by both, GC-MSMS and LC-HRMSMS. As neither 18-methyl-testosterone, nor 18-methyl-19-nortestosterone were detectable in the supplements, the possibility that the metabolite originates from methoxydienone was investigated. For this purpose, the metabolic fate of methoxydienone was studied in vitro using human HepG2 cells as well as in vivo by a single oral administration. While the 18-methyl-19-nortestosterone metabolite was not generated by HepG2 cells incubated with methoxydienone, it was observed in the urine samples collected at two, six, ten and 24 hours after methoxydienone administration. Moreover, the potential binding of methoxydienone as ligand to the human androgen receptor was modelled in silico in comparison to 18-methylnandrolone, for which androgen receptor activation had been shown in an in vitro approach before. In conclusion, we could ascribe the presence of the 18-methyl-19-nortestosterone metabolite in a forensic urine sample to originate from methoxydienone present in dietary supplements. Methoxydienone was observed to be slowly degrade by demethylation of the methoxy substituent in liquid solutions. While no compound-specific intermediates were identified that allowed differentiation from other 18-methylsteroids, the 18-methyl-19-nortestosterone metabolite proved to be a suitable marker for reliable detection in doping analysis.
Collapse
Affiliation(s)
- Detlef Thieme
- Institute of Doping Analysis and Sports Biochemistry Dresden, Kreischa, Germany
| | - Patricia Anielski
- Institute of Doping Analysis and Sports Biochemistry Dresden, Kreischa, Germany
| | - Sebastian Rzeppa
- Institute of Doping Analysis and Sports Biochemistry Dresden, Kreischa, Germany
| | - Clemens A Wolf
- Molecular Design Lab, Institute of Pharmacy, Department of Biology, Chemistry and Pharmacy, Freie Universität Berlin, Berlin, Germany
| | - Gerhard Wolber
- Molecular Design Lab, Institute of Pharmacy, Department of Biology, Chemistry and Pharmacy, Freie Universität Berlin, Berlin, Germany
| | - Annekathrin M Keiler
- Institute of Doping Analysis and Sports Biochemistry Dresden, Kreischa, Germany.,Environmental Monitoring & Endocrinology, Faculty of Biology, Technische Universität Dresden, Dresden, Germany
| |
Collapse
|
2
|
Iannella L, Comunità F, Botrè F, Colamonici C, Curcio D, de la Torre X, Mazzarino M. Urinary excretion profile of prednisolone and prednisone after rectal administration: significance in anti doping analysis. Drug Test Anal 2022; 14:2007-2016. [PMID: 35921255 PMCID: PMC10087643 DOI: 10.1002/dta.3352] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/28/2022] [Revised: 07/29/2022] [Accepted: 07/29/2022] [Indexed: 11/10/2022]
Abstract
The rectal administration of glucocorticoids, as well as any injectable, and oral ones, is currently prohibited by the World Anti-Doping Agency when occurs "in competition". A reporting level of 100 ng/mL for prednisolone and 300 ng/mL for prednisone was established to discriminate the allowed and the prohibited administration. Here, the urinary excretion profiles of prednisone and prednisolone were evaluated in five volunteers in therapy with glucocorticoid-based rectal formulations containing prednisone or prednisolone caproate. The urinary levels of the excreted target compounds were determined by LC-MS/MS following the procedure validated and currently in use in our laboratory to detect and quantitate glucocorticoids in urine. Predictably, the excretion trend of the analytes of interest were generally comparable to those obtained after oral administration, even if the excretion profile showed a broad inter-individual variability, with the absorption rate and the systemic bioavailability after rectal administration being strongly influenced by the type of formulations (suppository or rectal cream, in our case) as well as the physiological conditions of the absorption area. Results showed that the target compounds were detectable for at least 30 hours after drug administration. After suppository administration, prednisolone levels reached the maximum after 3 hours from drug administration, and then dropped below the reporting level after 15-21 hours; prednisone reached the maximum after 3 hours from drug administration, and then dropped below the reporting level after 12-15 hours. After cream administration both prednisone and prednisolone levels remained in a concentration below the reporting level throughout the entire monitored period.
Collapse
Affiliation(s)
- Loredana Iannella
- Laboratorio Antidoping, Federazione Medico Sportiva Italiana, Rome, Italy
| | - Fabio Comunità
- Laboratorio Antidoping, Federazione Medico Sportiva Italiana, Rome, Italy
| | - Francesco Botrè
- Laboratorio Antidoping, Federazione Medico Sportiva Italiana, Rome, Italy.,REDs - Research and Expertise in anti-Doping sciences, ISSUL - Institute of Sport Sciences, University of Lausanne, Lausanne, Switzerland
| | | | - Davide Curcio
- Laboratorio Antidoping, Federazione Medico Sportiva Italiana, Rome, Italy
| | - Xavier de la Torre
- Laboratorio Antidoping, Federazione Medico Sportiva Italiana, Rome, Italy
| | - Monica Mazzarino
- Laboratorio Antidoping, Federazione Medico Sportiva Italiana, Rome, Italy
| |
Collapse
|
3
|
de L Castro J, Pereira HMG, de Sousa VP, Martucci MEP. Evaluation of Dermorphin Metabolism Using Zebrafish Water Tank Model and Human Liver Microsomes. Curr Drug Metab 2021; 22:372-382. [PMID: 33593255 DOI: 10.2174/1389200222666210216095753] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/02/2020] [Revised: 12/31/2020] [Accepted: 01/12/2021] [Indexed: 11/22/2022]
Abstract
BACKGROUND Dermorphin is a heptapeptide with an analgesic potential higher than morphine that does not present the same risk for the development of tolerance. These pharmacological features make dermorphin a potential doping agent in competitive sports and it is already prohibited for racehorses. For athletes, the development of an efficient strategy to monitor for its abuse necessitates an investigation of the metabolism of dermorphin in humans. METHODS Here, human liver microsomes and zebrafish were utilized as model systems of human metabolism to evaluate the presence and kinetics of metabolites derived from dermorphin. Five hours after its administration, the presence of dermorphin metabolites could be detected in both models by liquid chromatography coupled to highresolution mass spectrometry. RESULTS Although the two models showed common results, marked differences were also observed in relation to the formed metabolites. Six putative metabolites, based on their exact masses of m/z 479.1915, m/z 501.1733, m/z 495.1657, m/z 223.1073, m/z 180.1017 and m/z 457.2085, are proposed to represent the metabolic pattern of dermorphin. The major metabolite generated from the administration of dermorphin in both models was YAFG-OH (m/z 457.2085), which is the N-terminal tetrapeptide previously identified from studies on rats. CONCLUSION Its extensive characterization and commercial availability suggest that it could serve as a primary target analyte for the detection of dermorphin misuse. The metabolomics approach also allowed the assignment of other confirmatory metabolites.
Collapse
Affiliation(s)
- Juliana de L Castro
- Departamento de Farmacos e Medicamentos, Faculdade de Farmacia, Universidade Federal do Rio de Janeiro, Av. Carlos Chagas Filho, 373, CCS, Cidade Universitaria, 21941-902, Rio de Janeiro, RJ, Brazil
| | - Henrique M G Pereira
- Instituto de Quimica, Universidade Federal do Rio de Janeiro, LBCD-LADETEC. Av. Horacio Macedo, 1280, Polo de Quimica, Bloco C, Cidade Universitaria, 21941-598 Rio de Janeiro, RJ, Brazil
| | - Valéria P de Sousa
- Departamento de Farmacos e Medicamentos, Faculdade de Farmacia, Universidade Federal do Rio de Janeiro, Av. Carlos Chagas Filho, 373, CCS, Cidade Universitaria, 21941-902, Rio de Janeiro, RJ, Brazil
| | - Maria E P Martucci
- Departamento de Farmacia, Escola de Farmacia, Universidade Federal De Ouro Preto, Rua 9, Campus Morro do Cruzeiro, Bauxita, 35400-000, Ouro Preto, MG, Brazil
| |
Collapse
|
4
|
Kiousi P, Fragkaki AG, Kioukia-Fougia N, Angelis YS. Liquid chromatography-mass spectrometry behavior of Girard's reagent T derivatives of oxosteroid intact phase II metabolites for doping control purposes. Drug Test Anal 2021; 13:1822-1834. [PMID: 33942526 DOI: 10.1002/dta.3056] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/28/2021] [Revised: 04/27/2021] [Accepted: 04/27/2021] [Indexed: 11/10/2022]
Abstract
Intact phase II steroid metabolites have poor product ion mass spectra under collision-induced dissociation (CID) conditions. Therefore, we present herein the liquid chromatography-electrospray ionization-tandem mass spectrometry (LC-ESI-MS/(MS)) behavior of intact phase II metabolites of oxosteroids after derivatization. Based on the fact that Girard's reagent T (GRT), as derivatization reagent, was both convenient and efficient in terms of the enhancement in the ionization efficiency and the production of diagnostic product ions related to the steroid moiety, the latter was preferably selected between methoxamine and hydroxylamine upon the model compounds of androsterone glucuronide and androsterone sulfate. Sixteen different glucuronides and 29 sulfate conjugated metabolites of anabolic androgenic steroids (AASs), available either as pure reference materials or synthesized/extracted from administration studies, were derivatized with GRT, and their product ion spectra are presented. Product ion spectra include in all cases high number of product ions that in some cases are characteristic for certain structures of the steroid backbone. More specifically, preliminary results have shown major differences in fragmentation pattern for 17α/17β-isomers of the sulfate conjugates, but limited differentiation for 17α/17β-isomers of glucuronide conjugates and for 3α/3β- and 5α/5β-stereoisomers of both sulfate and glucuronide conjugates. Further to the suggestion of the current work, application on mesterolone administration studies confirmed-according to the World Anti-Doping Agency (WADA) TD2015IDCR-the presence of seven intact phase II metabolites, one glucuronide and six sulfates with use of LC-ESI-MS/(MS).
Collapse
Affiliation(s)
- Polyxeni Kiousi
- Doping Control Laboratory of Athens, Institute of Biosciences and Applications, National Center for Scientific Research "Demokritos", Athens, Greece
| | - Argyro G Fragkaki
- Doping Control Laboratory of Athens, Institute of Biosciences and Applications, National Center for Scientific Research "Demokritos", Athens, Greece
| | - Nassia Kioukia-Fougia
- Doping Control Laboratory of Athens, Institute of Biosciences and Applications, National Center for Scientific Research "Demokritos", Athens, Greece
| | - Yiannis S Angelis
- Doping Control Laboratory of Athens, Institute of Biosciences and Applications, National Center for Scientific Research "Demokritos", Athens, Greece
| |
Collapse
|
5
|
|
6
|
Forsdahl G, Geisendorfer T, Göschl L, Pfeffer S, Gärtner P, Thevis M, Gmeiner G. Unambiguous identification and characterization of a long-term human metabolite of dehydrochloromethyltestosterone. Drug Test Anal 2018; 10:1244-1250. [PMID: 29570240 DOI: 10.1002/dta.2385] [Citation(s) in RCA: 22] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/19/2017] [Revised: 02/17/2018] [Accepted: 03/10/2018] [Indexed: 01/28/2023]
Abstract
In doping control analysis, the characterization of urinary steroid metabolites is of high interest for a targeted and long-term detection of prohibited anabolic androgenic steroids (AAS). In this work, the structure of a long-term metabolite of dehydrochloromethyltestosterone (DHCMT) was elucidated. Altogether, 8 possible metabolites with a 17α-methyl-17β-hydroxymethyl - structures were synthesized and compared to a major DHCMT long-term metabolite detected in reference urine excretion samples. The confirmed structure of the metabolite was 4α-chloro-18-nor-17β-hydroxymethyl-17α-methyl-5α-androst-13-en-3α-ol.
Collapse
Affiliation(s)
- Guro Forsdahl
- Doping Control Laboratory, Seibersdorf Labor GmbH, Seibersdorf, Austria
- Department of Pharmacy, University of Tromsø - The Arctic University of Norway, Tromsø, Norway
| | | | - Lorenz Göschl
- Doping Control Laboratory, Seibersdorf Labor GmbH, Seibersdorf, Austria
| | - Sandra Pfeffer
- Doping Control Laboratory, Seibersdorf Labor GmbH, Seibersdorf, Austria
| | - Peter Gärtner
- Institute of Applied Synthetic Chemistry, TU Wien, Vienna, Austria
| | - Mario Thevis
- Institute of Biochemistry, Center for Preventive Doping Research, German Sport University, Cologne, Germany
| | - Günter Gmeiner
- Doping Control Laboratory, Seibersdorf Labor GmbH, Seibersdorf, Austria
| |
Collapse
|
7
|
Balcells G, Gómez C, Garrostas L, Pozo ÓJ, Ventura R. Sulfate metabolites as alternative markers for the detection of 4-chlorometandienone misuse in doping control. Drug Test Anal 2016; 9:983-993. [PMID: 27686240 DOI: 10.1002/dta.2101] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/10/2016] [Revised: 09/06/2016] [Accepted: 09/27/2016] [Indexed: 11/10/2022]
Abstract
Sulfate metabolites have been described as long-term metabolites for some anabolic androgenic steroids (AAS). 4-chlorometandienone (4Cl-MTD) is one of the most frequently detected AAS in sports drug testing and it is commonly detected by monitoring metabolites excreted free or conjugated with glucuronic acid. Sulfation reactions of 4Cl-MTD have not been studied. The aim of this work was to evaluate the sulfate fraction of 4Cl-MTD metabolism by liquid chromatography-tandem mass spectrometry (LC-MS/MS) to establish potential long-term metabolites valuable for doping control purposes. 4Cl-MTD was administered to two healthy male volunteers and urine samples were collected up to 8 days after administration. A theoretical selected reaction monitoring (SRM) method working in negative mode was developed. Ion transitions were based on ionization and fragmentation behaviour of sulfate metabolites as well as specific neutral losses (NL of 15 Da and NL of 36 Da) of compounds with related chemical structure. Six sulfate metabolites were detected after the analysis of excretion study samples. Three of the identified metabolites were characterized by liquid chromatography-tandem mass spectrometry (LC-MS/MS) and gas chromatography-tandem mass spectrometry (GC-MS/MS). Results showed that five out of the six identified sulfate metabolites were detected in urine up to the last collected samples from both excretion studies. Copyright © 2016 John Wiley & Sons, Ltd.
Collapse
Affiliation(s)
- Georgina Balcells
- Bioanalysis Research Group, IMIM, Hospital del Mar Medical Research Institute, Barcelona, Spain.,Department of Experimental and Health Sciences, Universitat Pompeu Fabra, Barcelona, Spain
| | - Cristina Gómez
- Bioanalysis Research Group, IMIM, Hospital del Mar Medical Research Institute, Barcelona, Spain.,Experimental Asthma and Allergy Research Unit, The National Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.,Unit for Chemistry II, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden
| | - Lorena Garrostas
- Bioanalysis Research Group, IMIM, Hospital del Mar Medical Research Institute, Barcelona, Spain
| | - Óscar J Pozo
- Bioanalysis Research Group, IMIM, Hospital del Mar Medical Research Institute, Barcelona, Spain
| | - Rosa Ventura
- Bioanalysis Research Group, IMIM, Hospital del Mar Medical Research Institute, Barcelona, Spain.,Department of Experimental and Health Sciences, Universitat Pompeu Fabra, Barcelona, Spain
| |
Collapse
|
8
|
Dyreborg A, Krogh N, Backer V, Rzeppa S, Hemmersbach P, Hostrup M. Pharmacokinetics of Oral and Inhaled Terbutaline after Exercise in Trained Men. Front Pharmacol 2016; 7:150. [PMID: 27375484 PMCID: PMC4901060 DOI: 10.3389/fphar.2016.00150] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/15/2016] [Accepted: 05/24/2016] [Indexed: 11/20/2022] Open
Abstract
Aim: The aim of the study was to investigate pharmacokinetics of terbutaline after oral and inhaled administration in healthy trained male subjects in relation to doping control. Methods: Twelve healthy well-trained young men (27 ±2 years; mean ± SE) underwent two pharmacokinetic trials that compared 10 mg oral terbutaline with 4 mg inhaled dry powder terbutaline. During each trial, subjects performed 90 min of bike ergometer exercise at 65% of maximal oxygen consumption. Blood (0–4 h) and urine (0–24 h) samples were collected before and after administration of terbutaline. Samples were analyzed for concentrations of terbutaline by high performance liquid chromatography coupled to tandem mass spectrometry (HPLC-MS/MS). Results: Pharmacokinetics differed between the two routes of administration. Serum Cmax and area under the serum concentration-time curve (AUC) were lower after oral administration compared to inhalation (Cmax: 4.2 ± 0.3 vs. 8.5 ± 0.7 ng/ml, P ≤ 0.001; AUC: 422 ± 22 vs. 1308 ± 119 ng/ml × min). Urine concentrations (sum of the free drug and the glucuronide) were lower after oral administration compared to inhalation 2 h (1100 ± 204 vs. 61 ± 10 ng/ml, P ≤ 0.05) and 4 h (734 ± 110 vs. 340 ± 48 ng/ml, P ≤ 0.001) following administration, whereas concentrations were higher for oral administration than inhalation 12 h following administration (190 ± 41 vs. 399 ± 108 ng/ml, P ≤ 0.05). Urine excretion rate was lower after oral administration than inhalation the first 2 h following administration (P ≤ 0.001). Systemic bioavailability ratio between the two routes of administration was 3.8:1 (inhaled: oral; P ≤ 0.001). Conclusion: Given the higher systemic bioavailability of inhaled terbutaline compared to oral, our results indicate that it is difficult to differentiate allowed inhaled use of terbutaline from prohibited oral ingestion based on urine concentrations in doping control analysis. However given the potential performance enhancing effect of high dose terbutaline, it is essential to establish a limit on the WADA doping list.
Collapse
Affiliation(s)
- Anders Dyreborg
- Respiratory Research Unit, Bispebjerg Hospital Copenhagen, Denmark
| | - Nanna Krogh
- Respiratory Research Unit, Bispebjerg Hospital Copenhagen, Denmark
| | - Vibeke Backer
- Respiratory Research Unit, Bispebjerg HospitalCopenhagen, Denmark; IOC Sports MedicineCopenhagen, Denmark
| | - Sebastian Rzeppa
- Norwegian Doping Control Laboratory, Oslo University Hospital Oslo, Norway
| | - Peter Hemmersbach
- Norwegian Doping Control Laboratory, Oslo University Hospital Oslo, Norway
| | - Morten Hostrup
- Respiratory Research Unit, Bispebjerg HospitalCopenhagen, Denmark; IOC Sports MedicineCopenhagen, Denmark; Department of Nutrition, Exercise, and Sports, University of CopenhagenCopenhagen, Denmark
| |
Collapse
|
9
|
Kiousi P, Angelis YS, Fragkaki AG, Abushareeda W, Alsayrafi M, Georgakopoulos C, Lyris E. Markers of mesterolone abuse in sulfate fraction for doping control in human urine. J Mass Spectrom 2015; 50:1409-1419. [PMID: 26634976 DOI: 10.1002/jms.3715] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/27/2015] [Revised: 10/05/2015] [Accepted: 10/08/2015] [Indexed: 06/05/2023]
Abstract
This manuscript describes the direct detection of mesteroloe sulfo-conjugated metabolites by liquid chromatography/quadrupole/time of flight mass spectrometry (LC/Q/TOFMS) with special focus on evaluation of their retrospective detectability and their structure elucidation. A comparison of their long-term detectability, with the mesterolone main metabolite (1α-methyl-5α-androstan-3α-ol-17-one) excreted in glucuronide fraction and detected by gas chromatography/high resolution mass spectrometry (GC/HRMS), is also presented. Studies on mesterolone were performed with samples obtained from two excretion studies after single oral administration of Proviron© by healthy volunteers. Potential sulfate metabolites were detected in post administration samples after liquid-liquid extraction (LLE) with ethyl acetate and LC/TOFMS analysis, in negative mode. Twelve mesterolone sulfate metabolites from the first excretion study and nine from the second were subsequently confirmed by LC/Q/TOFMS. Finally, six mesterolone sulfate metabolites were considered important taking into account their abundance and long-term detectability, encoded as M1, M2, M4, M5, M6 and M7. The proposed mesterolone sulfate metabolites M1, M2, M4 and M5 (excreted as sulfates) have the same retrospectivity with the main mesterolone metabolite, excreted in glucuronide fraction. For metabolite characterization, LC fractionation was performed. The metabolites were identified and characterized by GC/MS, after solvolysis and derivatization. Combined mass spectra data from trimethyl-silyl (TMS), TMS-enolTMS and methoxime-TMS derivatives were taken into account for the characterization of these metabolites. It was concluded that M1 is 1α-methyl-5α-androstan-3β-ol-17 one, M2 is 1α-methyl-5α-androstan-3α-ol-17 one, M4 is 1α-methyl-5a-androstan-3β, 16z-diol-17-one, M5 is 1α-methyl-5α-androstan-17z,4ξ-diol-3one, M6 is 1α-methyl-5α-androstan-3z,6z-diol-17-one and M7 is 4z-hydroxy-1α-methyl-5α-androstan-3,17-dione.
Collapse
Affiliation(s)
- P Kiousi
- Doping Control Laboratory of Athens, Olympic Athletic Center of Athens 'Spyros Louis', 37 Kifisias Avenue, 15123, Maroussi, Greece
| | - Y S Angelis
- Doping Control Laboratory of Athens, Olympic Athletic Center of Athens 'Spyros Louis', 37 Kifisias Avenue, 15123, Maroussi, Greece
| | - A G Fragkaki
- Doping Control Laboratory of Athens, Olympic Athletic Center of Athens 'Spyros Louis', 37 Kifisias Avenue, 15123, Maroussi, Greece
| | - W Abushareeda
- Anti-Doping Laboratory of Qatar, PO Box 27775, Doha, Qatar
| | - M Alsayrafi
- Anti-Doping Laboratory of Qatar, PO Box 27775, Doha, Qatar
| | | | - E Lyris
- Doping Control Laboratory of Athens, Olympic Athletic Center of Athens 'Spyros Louis', 37 Kifisias Avenue, 15123, Maroussi, Greece
| |
Collapse
|
10
|
van den Broek I, Blokland M, Nessen MA, Sterk S. Current trends in mass spectrometry of peptides and proteins: Application to veterinary and sports-doping control. Mass Spectrom Rev 2015; 34:571-594. [PMID: 24375671 DOI: 10.1002/mas.21419] [Citation(s) in RCA: 34] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/05/2013] [Revised: 11/12/2013] [Accepted: 11/12/2013] [Indexed: 06/03/2023]
Abstract
Detection of misuse of peptides and proteins as growth promoters is a major issue for sport and food regulatory agencies. The limitations of current analytical detection strategies for this class of compounds, in combination with their efficacy in growth-promoting effects, make peptide and protein drugs highly susceptible to abuse by either athletes or farmers who seek for products to illicitly enhance muscle growth. Mass spectrometry (MS) for qualitative analysis of peptides and proteins is well-established, particularly due to tremendous efforts in the proteomics community. Similarly, due to advancements in targeted proteomic strategies and the rapid growth of protein-based biopharmaceuticals, MS for quantitative analysis of peptides and proteins is becoming more widely accepted. These continuous advances in MS instrumentation and MS-based methodologies offer enormous opportunities for detection and confirmation of peptides and proteins. Therefore, MS seems to be the method of choice to improve the qualitative and quantitative analysis of peptide and proteins with growth-promoting properties. This review aims to address the opportunities of MS for peptide and protein analysis in veterinary control and sports-doping control with a particular focus on detection of illicit growth promotion. An overview of potential peptide and protein targets, including their amino acid sequence characteristics and current MS-based detection strategies is, therefore, provided. Furthermore, improvements of current and new detection strategies with state-of-the-art MS instrumentation are discussed for qualitative and quantitative approaches.
Collapse
Affiliation(s)
- Irene van den Broek
- RIKILT Wageningen UR, Institute of Food Safety, Akkermaalsbos 2, 6708, WB, Wageningen, The Netherlands
- Department of Clinical Chemistry and Laboratory Medicine, Leiden University Medical Center (LUMC), Albinusdreef 2, 2333, ZA, Leiden, The Netherlands
| | - Marco Blokland
- RIKILT Wageningen UR, Institute of Food Safety, Akkermaalsbos 2, 6708, WB, Wageningen, The Netherlands
| | - Merel A Nessen
- RIKILT Wageningen UR, Institute of Food Safety, Akkermaalsbos 2, 6708, WB, Wageningen, The Netherlands
| | - Saskia Sterk
- RIKILT Wageningen UR, Institute of Food Safety, Akkermaalsbos 2, 6708, WB, Wageningen, The Netherlands
| |
Collapse
|
11
|
Fragkaki AG, Angelis YS, Kiousi P, Georgakopoulos CG, Lyris E. Comparison of sulfo-conjugated and gluco-conjugated urinary metabolites for detection of methenolone misuse in doping control by LC-HRMS, GC-MS and GC-HRMS. J Mass Spectrom 2015; 50:740-748. [PMID: 26259657 DOI: 10.1002/jms.3583] [Citation(s) in RCA: 29] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/08/2014] [Revised: 02/20/2015] [Accepted: 02/21/2015] [Indexed: 06/04/2023]
Abstract
Methenolone (17β-hydroxy-1-methyl-5α-androst-1-en-3-one) misuse in doping control is commonly detected by monitoring the parent molecule and its metabolite (1-methylene-5α-androstan-3α-ol-17-one) excreted conjugated with glucuronic acid using gas chromatography-mass spectrometry (GC-MS) and liquid chromatography mass spectrometry (LC-MS) for the parent molecule, after hydrolysis with β-glucuronidase. The aim of the present study was the evaluation of the sulfate fraction of methenolone metabolism by LC-high resolution (HR)MS and the estimation of the long-term detectability of its sulfate metabolites analyzed by liquid chromatography tandem mass spectrometry (LC-HRMSMS) compared with the current practice for the detection of methenolone misuse used by the anti-doping laboratories. Methenolone was administered to two healthy male volunteers, and urine samples were collected up to 12 and 26 days, respectively. Ethyl acetate extraction at weak alkaline pH was performed and then the sulfate conjugates were analyzed by LC-HRMS using electrospray ionization in negative mode searching for [M-H](-) ions corresponding to potential sulfate structures (comprising structure alterations such as hydroxylations, oxidations, reductions and combinations of them). Eight sulfate metabolites were finally detected, but four of them were considered important as the most abundant and long term detectable. LC clean up followed by solvolysis and GC/MS analysis of trimethylsilylated (TMS) derivatives reveal that the sulfate analogs of methenolone as well as of 1-methylene-5α-androstan-3α-ol-17-one, 3z-hydroxy-1β-methyl-5α-androstan-17-one and 16β-hydroxy-1-methyl-5α-androst-1-ene-3,17-dione were the major metabolites in the sulfate fraction. The results of the present study also document for the first time the methenolone sulfate as well as the 3z-hydroxy-1β-methyl-5α-androstan-17-one sulfate as metabolites of methenolone in human urine. The time window for the detectability of methenolone sulfate metabolites by LC-HRMS is comparable with that of their hydrolyzed glucuronide analogs analyzed by GC-MS. The results of the study demonstrate the importance of sulfation as a phase II metabolic pathway for methenolone metabolism, proposing four metabolites as significant components of the sulfate fraction.
Collapse
Affiliation(s)
- A G Fragkaki
- Doping Control Laboratory of Athens, Olympic Athletic Center of Athens 'Spyros Louis', 37 Kifisias Avenue, 15123, Marousi, Greece
| | - Y S Angelis
- Doping Control Laboratory of Athens, Olympic Athletic Center of Athens 'Spyros Louis', 37 Kifisias Avenue, 15123, Marousi, Greece
| | - P Kiousi
- Doping Control Laboratory of Athens, Olympic Athletic Center of Athens 'Spyros Louis', 37 Kifisias Avenue, 15123, Marousi, Greece
| | | | - E Lyris
- Doping Control Laboratory of Athens, Olympic Athletic Center of Athens 'Spyros Louis', 37 Kifisias Avenue, 15123, Marousi, Greece
| |
Collapse
|
12
|
Matabosch X, Pozo OJ, Pérez-Mañá C, Papaseit E, Segura J, Ventura R. Detection and characterization of prednisolone metabolites in human urine by LC-MS/MS. J Mass Spectrom 2015; 50:633-642. [PMID: 25800201 DOI: 10.1002/jms.3571] [Citation(s) in RCA: 21] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/04/2014] [Revised: 01/07/2015] [Accepted: 01/07/2015] [Indexed: 06/04/2023]
Abstract
Glucocorticosteroids are prohibited in sports when used by systemic administrations (e.g. oral), whereas they are allowed using other administration ways. Strategies to discriminate between administrations routes have to be developed by doping control laboratories. For this reason, the metabolism of prednisolone (PRED) was studied using liquid chromatography coupled to tandem mass spectrometry. A single oral (10 mg) dose of PRED was administered to two healthy male volunteers. Urine samples were collected up to 6 days after administration. Samples were hydrolyzed with β-glucuronidase and subjected to liquid-liquid extraction with ethyl acetate in alkaline conditions. The extracts were analyzed by liquid chromatography coupled to tandem mass spectrometry. Precursor ion scan methods (m/z 77, 91, 105, 121, 147 and 171) in positive ionization and neutral loss scan methods (76 and 94 Da) in negative ionization modes were applied for the open detection of PRED metabolites. Using these methods, PRED parent compound plus 20 metabolites were detected. PRED and 11 metabolites were characterized by comparison with standards of the compounds (PRED, prednisone, 20β-dihydro-PRED and 20α-dihydro-PRED, 20β-dihydro-prednisone and 20α-dihydro-prednisone, 6β-hydroxy-PRED and 6α-hydroxy-PRED, 20β isomers and 20α isomers of 6β,11β,17α,20,21-pentahydroxypregnan-1,4-diene-3-one, 6α,11β,17α,20β,21-pentahydroxypregnan-1,4-diene-3-one and Δ(6) -PRED). Using mass spectrometric data, feasible structures were proposed for seven of the remaining nine detected metabolites, including several 6-hydroxy-metabolites. Eleven of the characterized metabolites have not been previously described. Maximum excretion rates for PRED metabolites were achieved in first 24 h; however, most of the metabolites were still detectable in the last collected samples (day 6).
Collapse
Affiliation(s)
- Xavier Matabosch
- Bioanalysis Research Group, IMIM, Institut Hospital del Mar d'Investigacions Mèdiques, Doctor Aiguader 88, 08003, Barcelona, Spain
| | | | | | | | | | | |
Collapse
|
13
|
Hullstein I, Sagredo C, Hemmersbach P. Carbon isotope ratios of nandrolone, boldenone, and testosterone preparations seized in Norway compared to those of endogenously produced steroids in a Nordic reference population. Drug Test Anal 2014; 6:1163-9. [PMID: 25388436 DOI: 10.1002/dta.1745] [Citation(s) in RCA: 25] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/31/2014] [Revised: 10/01/2014] [Accepted: 10/03/2014] [Indexed: 11/11/2022]
Abstract
Determining the origin of anabolic androgenic steroids (AAS) that also are produced endogenously in the human body is a major issue in doping control. In some cases, the presence of nandrolone and boldenone metabolites might result from endogenous production. The GC-C-IRMS technique (gas chromatography-combustion-isotope ratio mass spectrometry) enables the carbon isotopic ratio (CIR) to be measured to determine the origin of these metabolites. The aim of this study was to use GC-C-IRMS to determine the δ(13) CVPDB values of seized boldenone and nandrolone preparations to decide if the steroids themselves were depleted in (13) C, compared to what is normally seen in endogenously produced steroids. In addition, several testosterone preparations were analyzed. A total of 69 seized preparations were analyzed. The nandrolone preparations showed δ(13) CVPDB values in the range of -31.5 ‰ to -26.7 ‰. The boldenone preparations showed δ(13) CVPDB values in the range of -32.0 ‰ to -27.8 ‰, and for comparison the testosterone preparations showed δ(13) CVPDB values of -31.0 ‰ to -24.2 ‰. The results showed that the values measured in the nandrolone and boldenone preparations were in the same range as those measured in the testosterone preparations. The study also included measurements of CIR of endogenously produced steroids in a Norwegian/Danish reference population. The δ(13) CVPDB values measured for the endogenous steroids in this population were in the range of -21.7 to -26.8. In general, most of the preparations investigated in this study show (13) C-depleted delta values compared to endogenously produced steroids reflecting a northern European diet.
Collapse
Affiliation(s)
- Ingunn Hullstein
- Norwegian Doping Control Laboratory, Oslo University Hospital, Oslo, Norway
| | | | | |
Collapse
|
14
|
Affiliation(s)
- Tiia Kuuranne
- Doping Control Laboratory, United Medix Laboratories, Helsinki, Finland.
| |
Collapse
|